OBJECTIVE-Clinical islet transplantations are performed through infusion of islets via the portal vein into the liver. This study aimed at characterizing the influence of the implantation microenvironment on islet graft metabolism and function.RESEARCH DESIGN AND METHODS-Islets were transplanted into their normal environment, i.e., the pancreas, or intraportally into the liver of mice. One month posttransplantation, the transplanted islets were retrieved and investigated for changes in function and gene expression.RESULTS-Insulin content, glucose-stimulated insulin release, (pro)insulin biosynthesis, and glucose oxidation rate were markedly decreased in islets retrieved from the liver, both when compared with islets transplanted into the pancreas and endogenous islets. Islets transplanted into the pancreas showed normal insulin content, (pro)insulin biosynthesis, and glucose oxidation rate but increased basal insulin secretion and impaired glucose stimulation index. Gene expression data for retrieved islets showed downregulation of pancreatic and duodenal homeobox gene-1, GLUT-2, glucokinase, mitochondrial glycerol-phosphate dehydrogenase, and pyruvate carboxylase, preferentially in intraportally transplanted islets.CONCLUSIONS-Islets transplanted into their normal microenvironment, i.e., the pancreas, display gene expression changes when compared with endogenous islets but only moderate changes in metabolic functions. In contrast, site-specific properties of the liver markedly impaired the metabolic functions of intraportally transplanted islets. Diabetes 56:1544-1550, 2007 C linical islet transplantations have been almost exclusively performed through the intraportal route. However, despite recent advances in immunosuppressive regimens for islet allotransplantation, pancreatic islets from at least two donors are still needed to reverse hyperglycemia in type 1 diabetic patients using the intrahepatic site (1). The number of required islets is far greater than the alleged 10 -20% of the total islet volume suggested to be enough to maintain normoglycemia in humans. Follow-up studies from the Edmonton group also show that there is a continuous decline in function of intraportally transplanted islets, which results in very few patients remaining insulin independent beyond 4 years posttransplantation (2). These observations, together with the occurrence of an instant blood-mediated inflammatory reaction (when exposing human islets to blood [3,4]), have in recent years seriously questioned the liver as the implantation organ of choice for pancreatic islets.Although substantial islet cell death is likely to occur in the immediate posttransplantation period (3), dysfunction of surviving cells may also occur. This notion has been difficult to investigate, since islets implanted into the liver through the portal vein disperse within the liver parenchyma and therefore become unavailable for functional studies. However, we have recently described a method to retrieve intraportally transplanted mouse islets for functional s...